US trade rep threatens Colombia's peace process over legal plan to offer cheap leukemia meds
by Cory Doctorow from on (#1F8WJ)
Colombia wants to produce Novartis's leukemia drug imatinib under a compulsory license, something it is allowed to do under its trade agreement with the USA, to bring the price down from $15,161/year (double the annual average income) to prices like those charged in India ($803/year). (more")